V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310009174 | 310004019 | 1.67 | null | Palliative (P) | 2015-11-02 | 2015-11-05 | GEM-P | N | N | 310011160 | GEMCITABINE + PACLITAXEL |
| 310009175 | 310007659 | 1.63 | 70.8 | Palliative (P) | 2014-08-09 | 2014-08-31 | GEM-P | 02 | N | 310011181 | GEMCITABINE + PACLITAXEL |
| 310009176 | 310004022 | null | 62.1 | Palliative (P) | 2017-03-25 | 2017-04-16 | PEMBROLIZUMAB | N | N | 310011203 | PEMBROLIZUMAB |
| 310009177 | 310009589 | 1.64 | 57 | Curative (C) | 2018-09-08 | 2018-09-13 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310011249 | GEMCITABINE |
| 310009178 | 310004024 | 1.66 | 53.2 | Neo-adjuvant (N) | 2019-01-12 | 2019-05-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310011273 | CISPLATIN + GEMCITABINE |
| 310009179 | 310009591 | 1.62 | 97.09 | Palliative (P) | null | 2017-07-22 | Gemcitabine + Paclitaxel | N | N | 310011314 | GEMCITABINE + PACLITAXEL |
| 310009180 | 310004027 | 1.5 | 81.01 | Disease modification (D) | 2014-06-25 | 2014-06-25 | Brentuximab | 02 | N | 310011361 | BRENTUXIMAB |
| 310009181 | 310004029 | 1.79 | null | Curative (C) | 2015-03-10 | 2015-04-03 | LEAM | N | N | 310011381 | LEAM |
| 310009182 | 310009592 | 1.79 | 76.9 | Palliative (P) | 2016-06-20 | 2016-07-13 | PEMBROLIZUMAB | N | null | 310011437 | PEMBROLIZUMAB |
| 310009183 | 310009592 | 1.63 | null | Curative (C) | null | 2018-01-06 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | null | 310011437 | NOT MATCHED |
| 310009184 | 310004033 | 1.65 | 80.9 | Palliative (P) | 2017-10-25 | 2017-11-05 | GEMCITABINE | N | N | 310011581 | GEMCITABINE |
| 310009185 | 310010616 | 1.6 | 93.6 | Palliative (P) | 2017-02-03 | 2017-02-03 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310011701 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009186 | 310004036 | 1.59 | 83 | Palliative (P) | 2016-01-25 | 2016-01-30 | PEMBROLIZUMAB | N | N | 310011707 | PEMBROLIZUMAB |
| 310009187 | 310007669 | 1.7 | 63.9 | Palliative (P) | 2018-02-28 | 2018-02-28 | Carboplatin + Liposomal Doxorubicin | N | N | 310011854 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009188 | 310009594 | null | null | Palliative (P) | 2016-05-25 | 2016-12-08 | Gemcitabine weekly | 02 | null | 310011893 | GEMCITABINE |
| 310009189 | 310004042 | 1.67 | 81.7 | Curative (C) | 2014-08-29 | 2014-08-29 | LEAM | 2 | null | 310012033 | LEAM |
| 310009190 | 310007670 | 1.5 | 63 | Palliative (P) | 2018-10-05 | 2018-10-05 | Carboplatin + Liposomal Doxorubicin | Y | N | 310012033 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009191 | 310004044 | 1.76 | null | Palliative (P) | 2018-11-18 | 2018-11-23 | LEAM | N | N | 310012083 | LEAM |
| 310009192 | 310004046 | null | 116.4 | Disease modification (D) | 2017-08-29 | 2017-10-05 | Crisantaspase + METHOTREXATE | N | N | 310012125 | NOT MATCHED |
| 310009193 | 310004047 | 1.79 | 87.05 | Disease modification (D) | 2017-12-16 | 2017-12-16 | IVE | N | N | 310012152 | IVE |
| 310009194 | 310004049 | 1.75 | 89.6 | Curative (C) | 2012-02-24 | 2016-01-10 | NB HRNBL-1 Isotretinoin | 02 | null | 310012172 | NOT MATCHED |
| 310009195 | 310004051 | 1.67 | 9.7 | Curative (C) | 2017-04-20 | 2017-04-27 | BEAM | 2 | N | 310012172 | BEAM |
| 310009196 | 310004053 | 1.66 | 101 | Curative (C) | 2016-02-29 | 2016-03-07 | GEM-P | N | null | 310012235 | GEMCITABINE + PACLITAXEL |
| 310009197 | 310004053 | 1.5 | 82.5 | Palliative (P) | 2015-03-03 | 2015-03-09 | Gemcitabine + Methylprednisolone | 02 | N | 310012235 | GEMCITABINE |
| 310009198 | 310004053 | 1.63 | 61.6 | null | 2014-09-12 | 2014-09-18 | PEMBROLIZUMAB | 2 | N | 310012235 | PEMBROLIZUMAB |
| 310009199 | 310004055 | 1.63 | 63.2 | Palliative (P) | 2016-04-02 | 2016-10-23 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310012277 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009200 | 310004057 | 1.54 | 17.6 | Palliative (P) | null | 2015-09-07 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310012313 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009201 | 310004057 | null | 65.2 | Palliative (P) | 2015-12-10 | 2015-12-10 | GEMCITABINE | N | N | 310012313 | GEMCITABINE |
| 310009202 | 310004059 | null | 53.2 | Curative (C) | 2019-01-10 | 2019-01-15 | BEAM | Y | N | 310012453 | BEAM |
| 310009203 | 310004060 | 1.75 | 108 | Curative (C) | 2015-01-14 | 2015-01-18 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 02 | N | 310012526 | NOT MATCHED |
| 310009204 | 310004062 | 1.59 | 73 | Not known (9) | 2017-12-19 | 2017-12-19 | LEAM | N | N | 310012562 | LEAM |
| 310009205 | 310004067 | 1.65 | 49.7 | Palliative (P) | 2017-09-30 | 2017-12-21 | Brentuximab | N | N | 310012740 | BRENTUXIMAB |
| 310009206 | 310004068 | 1.57 | 90.2 | Curative (C) | 2018-06-17 | 2018-06-23 | IVE | 2 | N | 310012758 | IVE |
| 310009207 | 310004070 | 1.84 | 70.6 | null | 2018-08-23 | 2018-10-14 | GEMCITABINE | N | N | 310012763 | GEMCITABINE |
| 310009208 | 310004075 | 1.77 | 18 | Palliative (P) | 2018-06-30 | 2018-07-11 | PEMBROLIZUMAB | 02 | N | 310012944 | PEMBROLIZUMAB |
| 310009209 | 310004078 | 1.75 | 110.9 | Palliative (P) | 2018-09-28 | 2018-09-29 | Carboplatin + Liposomal Doxorubicin | N | N | 310012960 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009210 | 310004079 | 1.73 | 18 | Palliative (P) | 2015-07-20 | 2016-03-09 | Brentuximab | N | N | 310013003 | BRENTUXIMAB |
| 310009211 | 310004081 | 1.8 | 85.4 | Palliative (P) | 2018-07-17 | 2018-08-01 | Brentuximab Vedotin | N | N | 310013044 | BRENTUXIMAB |
| 310009212 | 310004084 | 1.72 | 68.5 | Neo-adjuvant (N) | 2017-03-06 | 2017-03-25 | NB HRNBL-1 BUMEL MAT | N | N | 310013083 | NOT MATCHED |
| 310009213 | 310004086 | 1.52 | 74 | Palliative (P) | 2013-08-26 | 2013-08-26 | Carboplatin + Liposomal Doxorubicin | 01 | N | 310013109 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009214 | 310004089 | 1.75 | null | Not known (9) | 2014-04-14 | 2014-05-06 | Cisplatin+Gemcitabine (gallbladder) | Y | N | 310013152 | CISPLATIN + GEMCITABINE |
| 310009215 | 310007694 | 1.56 | 62.5 | Palliative (P) | 2014-12-08 | 2014-12-08 | ALCL ALCL 99 Closed AM 1, 2 or 3 | Y | N | 310013153 | NOT MATCHED |
| 310009216 | 310004094 | 1.62 | 92 | Palliative (P) | 2011-12-01 | 2015-05-30 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310013153 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009217 | 310004099 | 1.73 | 92 | Palliative (P) | 2015-11-05 | 2015-11-05 | Gemcitabine weekly | 2 | null | 310013495 | GEMCITABINE |
| 310009218 | 310004100 | 1.75 | 63.4 | Palliative (P) | 2016-07-07 | 2018-06-14 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310013495 | CARBOPLATIN + LIPOSOMAL DOX |
| 310009219 | 310004102 | 1.68 | 55.5 | Curative (C) | 2014-05-24 | 2014-05-24 | IVE | 02 | Y | 310013647 | IVE |
| 310009220 | 310004102 | 1.68 | 118 | null | 2017-12-06 | 2017-12-09 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310013647 | GEMCITABINE |
| 310009221 | 310007703 | null | 111.85 | Palliative (P) | 2013-02-05 | 2013-03-09 | GEM-P | N | N | 310013796 | GEMCITABINE + PACLITAXEL |
| 310009222 | 310004105 | null | 58.9 | Palliative (P) | 2018-09-08 | 2018-12-09 | PEMBROLIZUMAB | null | Y | 310013814 | PEMBROLIZUMAB |
| 310009223 | 310004107 | 1.82 | 69.3 | Palliative (P) | 2016-05-07 | 2016-10-29 | PEMBROLIZUMAB | 02 | N | 310013899 | PEMBROLIZUMAB |